Optimizing thiopurine therapy in inflamm
โ
Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet; Miles P. Sparrow
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 113 KB
Despite recent advances, the therapeutic armamentarium for inflammatory bowel disease (IBD) is still limited. In addition, a step-up approach is recommended for most IBD patients. Thus, optimizing each medical therapy before switching to another drug class is the rule in clinical practice. Conventio